|
Market Closed -
NYSE
00:00:03 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 88.00 USD | -0.76% |
|
+1.85% | -12.72% |
| 10-29 | Clorox appoints Unilever executive as its new CEO | RE |
| 10-29 | Clorox Expected to Post Fiscal Q1 Results in Line With Consensus, RBC Says | MT |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 17,352 | 19,661 | 16,948 | 14,799 | 11,541 | 10,642 | - | - |
| Change | - | 13.31% | -13.8% | -12.68% | -22.02% | -7.79% | - | - |
| Enterprise Value (EV) 1 | 19,880 | 21,821 | 19,231 | 17,120 | 16,465 | 15,527 | 15,431 | 15,458 |
| Change | - | 9.77% | -11.87% | -10.98% | -3.83% | -5.7% | -0.61% | 0.17% |
| P/E | 37.8x | 133x | 60.7x | 18.4x | 19.8x | 15.6x | 14.2x | 13.5x |
| PBR | 31.2x | 89.5x | 51.7x | 45.9x | 128x | 60.3x | 49.7x | 33.8x |
| PEG | - | -2x | 0.7x | 0x | -0.8x | 0.9x | 1.4x | 2.72x |
| Capitalization / Revenue | 2.44x | 2.66x | 2.39x | 2.08x | 1.72x | 1.39x | 1.36x | 1.32x |
| EV / Revenue | 2.8x | 2.95x | 2.71x | 2.41x | 2.45x | 2.04x | 1.97x | 1.92x |
| EV / EBITDA | 20.4x | 18.9x | 15x | 11.2x | 12.9x | 11.3x | 10.5x | 10.1x |
| EV / EBIT | 26.5x | 23.8x | 18.4x | 13x | 16x | 13.9x | 12.9x | 12.2x |
| EV / FCF | 37.2x | 23.5x | 39.8x | 22.5x | 18.7x | 17.3x | 18.1x | 17x |
| FCF Yield | 2.69% | 4.26% | 2.51% | 4.45% | 5.35% | 5.77% | 5.54% | 5.88% |
| Dividend per Share 2 | 4.66 | 4.72 | 4.8 | 4.88 | 4.96 | 5.153 | 5.35 | 5.608 |
| Rate of return | 3.31% | 2.97% | 3.52% | 4.06% | 5.2% | 5.86% | 6.08% | 6.37% |
| EPS 2 | 3.73 | 1.2 | 2.25 | 6.52 | 4.81 | 5.63 | 6.205 | 6.513 |
| Distribution rate | 125% | 393% | 213% | 74.8% | 103% | 91.5% | 86.2% | 86.1% |
| Net sales 1 | 7,107 | 7,389 | 7,093 | 7,104 | 6,720 | 7,630 | 7,818 | 8,072 |
| EBITDA 1 | 974 | 1,153 | 1,280 | 1,535 | 1,277 | 1,379 | 1,471 | 1,535 |
| EBIT 1 | 750 | 917 | 1,045 | 1,316 | 1,030 | 1,116 | 1,199 | 1,268 |
| Net income 1 | 462 | 149 | 280 | 810 | 587 | 690.9 | 734.9 | 785.1 |
| Net Debt 1 | 2,528 | 2,160 | 2,283 | 2,321 | 4,924 | 4,885 | 4,789 | 4,816 |
| Reference price 2 | 140.98 | 159.04 | 136.47 | 120.07 | 95.44 | 88.00 | 88.00 | 88.00 |
| Nbr of stocks (in thousands) | 123,080 | 123,624 | 124,188 | 123,253 | 120,921 | 120,931 | - | - |
| Announcement Date | 03/08/22 | 02/08/23 | 01/08/24 | 31/07/25 | 03/08/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.63x | 2.04x | 11.26x | 5.86% | 10.64B | ||
| 18.12x | 3.26x | 11.8x | 4.55% | 46.01B | ||
| 28.92x | 4.37x | 18.64x | 1.15% | 25.31B | ||
| 14.56x | 1.67x | 9.52x | 3.88% | 4.98B | ||
| 19.7x | 0.97x | 7.37x | 1.87% | 3.21B | ||
| 33.74x | 4.07x | 22.58x | - | 2.95B | ||
| 12.5x | 1.43x | 8.62x | 10.54% | 2.91B | ||
| 27x | 1.15x | 18.44x | 3.9% | 1.8B | ||
| Average | 21.27x | 2.37x | 13.53x | 4.53% | 12.23B | |
| Weighted average by Cap. | 20.98x | 3.19x | 13.60x | 3.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions
















